InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Watanabe Todd, See Remarks. Insider active across 1 company, notably Arcutis Biotherapeutics, Inc.. In total, 9 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €2.2m. Activity tracked since 4 August 2025. The latest transaction was filed on 3 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Watanabe Todd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
4,375 股@ US$26.1168Common StockSEC:0001628280-26-053753:0
102,000 股0Common StockSEC:0001628280-26-014327:0
19,833 股@ US$25.498420.4% 占其流量Common StockSEC:0001628280-26-005570:0
1,055 股@ US$30.001.7% 占其流量Common StockSEC:0001801061-25-000012:0
11,478 股@ US$24.712215.1% 占其流量Common StockSEC:0001801061-25-000010:0
40,000 股@ US$25.02580.032% mcap50.0% 占其流量Common StockSEC:0001801061-25-000008:0
15,000 股@ US$18.913517.4% 占其流量Common StockSEC:0001801061-25-000006:0
9,625 股@ US$17.537612.5% 占其流量Common StockSEC:0001787306-25-000136:0
11,547 股@ US$14.32667.7% 占其流量Common StockSEC:0001787306-25-000119:0
9 条申报中的 9 条
About Watanabe Todd
Todd Watanabe is involved in various functions at Arcutis Biotherapeutics, Inc. His role includes specific responsibilities that contribute to the company's development and strategy. His expertise is an asset to the organization.
